Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of August 2025, with a report date of August 19, 2025. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively reports on specific share acquisition transactions.
| Transaction Date | Instrument | Price (USD) | Volume (ADSs) | Transaction Type |
|---|---|---|---|---|
| 2025-08-15 | American Depositary Shares (ADSs) | $39.3600 | 3,328.441 | Dividend Reinvestment (Executive Supplemental Savings Plan) |
| 2025-08-15 | American Depositary Shares (ADSs) | $39.3600 | 84.000 | Dividend Reinvestment (401(k) Plan) |
| 2025-08-15 | American Depositary Shares (ADSs) | $39.3600 | 61.934 | Dividend Reinvestment (Executive Supplemental Savings Plan) |
Material Changes
The filing does not report material changes to the company's financial position or operations compared to prior periods. It details routine, automated acquisitions of shares by executives resulting from dividend reinvestment plans.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory disclosure of specific transactions executed on the New York Stock Exchange (XNYS).
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were automatic acquisitions via dividend reinvestment, not open-market purchases or sales by the executives.
- Executives Involved: Dr. Hal Barron (Non-Executive Director) and James Ford (SVP and Group General Counsel).
- Share Price: The transactions occurred at a uniform price of $39.36 per ADS on August 15, 2025.
- Regulatory Context: This is an initial notification of transactions under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.